The Long-Term Predictive Accuracy of the Short Synacthen (Corticotropin) Stimulation Test for Assessment of the Hypothalamic-Pituitary-Adrenal Axis
The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
CONTEXT: The high-dose short Synacthen (corticotropin) test (SST) is widely used to investigate suspected secondary adrenal insufficiency, but concern remains about falsely reassuring results. OBJECTIVE: Our objective was to evaluate the long-term safety of the SST. METHOD: We retrospectively evaluated the clinical outcome in 178 patients who achieved 30-min cortisol values in the lowest 15th percentile of normal healthy responses. Thirty patients were later excluded because of missing case notes (20 patients) or unsubstantiated pituitary pathology (10 patients). The remaining 148 patients were divided into two groups: group 1, patients with cortisol response between the 5th and 15th percentiles of normal response (551-635 nmol/liter, 98 patients); and group 2, patients with borderline response between the 2.5th and 5th percentiles (510-550 nmol/liter, 50 patients). Patients did not receive routine glucocorticoid therapy, but those in group 2 were advised to take hydrocortisone in case of intercurrent illness. RESULTS: The median follow-up period from the initial SST was 4.2 yr (range, 4 months to 7 yr). A total of 137 patients showed no clinical or biochemical evidence of adrenal insufficiency during follow-up. Of the remaining 11 patients, seven became hypoadrenal after subsequent pituitary surgery or radiotherapy, one patient in group 1 developed adrenal insufficiency at 2 yr, and one patient in group 2 developed adrenal insufficiency at 6 months. The other two patients who were in group 2 had clinical diagnostic uncertainty. CONCLUSION: The high-dose SST is safe for the purpose of excluding clinically significant secondary adrenal insufficiency and is indicated as the first line of investigation for this purpose.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, a peak cortisol level higher than 18–20 μg/dL (depending on assay-specific reference ranges) practically rule out GC-induced AI [44,47].”
From Glucocorticoid withdrawal-an overview on when and how to diagnose adrenal insufficiency in clinical practice (2021) · cites this paper as [47]
In the citing paper
“It was judged reliable compared to ITT [46,47] and is safe for the patients.”
From Glucocorticoid withdrawal-an overview on when and how to diagnose adrenal insufficiency in clinical practice (2021) · cites this paper as [47]
In the citing paper
“The short Synacthen (corticotropin) test (SST) at the conventional dose of 250 mg has been validated against the”
From The short synacthen (corticotropin) test can be used to predict recovery of hypothalamo-pituitary-adrenal axis function (2018) · cites this paper as [14]
Citations
Cites
A RATIONAL APPROACH FOR ASSESSING THE HYPOTHALAMO-PITUITARY-ADRENAL AXIS
Stewart, P. M., Seckl, J. R., Corrie, J., Edwards, C. R. W., & Padfield, P. L. (1988) · The Lancet · doi:10.1016/s0140-6736(88)92020-x · Cited by 418 · cited 3×
“In case 4, a basal cortisol of 516 nmol/liter would suggest intact adrenal function (4, 19), but when the biochemical and the clinical pictures were considered carefully, hypoadrenalism was thought likely and the patient was treated.”
BackgroundMethodSelf-citationDiagnosis of Adrenal Insufficiency
Dorin, R. I., Qualls, C. R., & Crapo, L. M. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-3-200308050-00009 · Cited by 374 · cited 1×
“However, these reports were not confirmed by other studies (9, 11) and a recent metaanalysis showed the two doses to have similar diagnostic utility (25).”
ResultA low dose ACTH test to assess the function of the hypothalamic–pituitary–adrenal axis
Rasmuson, S., Olsson, T., & Hägg, E. (1996) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1996.600482.x · Cited by 249
Hazards of pharmacological tests of growth hormone secretion in childhood.
Shah, A., Stanhope, R., & Matthew, D. (1992) · BMJ · doi:10.1136/bmj.304.6820.173 · Cited by 249 · cited 1×
“ularly in young children (2) and in adults with seizure dis-”
BackgroundTordjman, K. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.4.1301 · Cited by 219 · cited 1×
“Over the last few years, the low-dose (1 g) SST was proposed as a more a sensitive alternative to the high-dose SST by some authors using the ITT or metyrapone as the reference tests (13, 24).”
MethodClark, Neylon, Raggatt, Sheppard, & Stewart (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00555.x · Cited by 207 · cited 6×
“This assay is equivalent to the previously described Bayer ACS 180 (20) using the same reagents on a larger automated platform.”
BackgroundMethodInfluentialLINDHOLM, J., & KEHLET, H. (1987) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1987.tb03638.x · Cited by 178
Plumpton, F. S., & Besser, G. M. (1969) · Journal of British Surgery · doi:10.1002/bjs.1800560315 · Cited by 170 · cited 8×
“because of the work by Plumpton and Besser (1), which”
BackgroundInfluentialThaler, L. M., & Blevins, L. S. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.8.5039 · Cited by 161 · cited 1×
“Over the last few years, the low-dose (1 g) SST was proposed as a more a sensitive alternative to the high-dose SST by some authors using the ITT or metyrapone as the reference tests (13, 24).”
MethodJones, S. L., Trainer, P. J., Perry, L., Wass, J. A. H., Besser, G. M., & Grossman, A. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb03793.x · Cited by 159
Cited by
Charmandari, E., Nicolaides, N. C., & Chrousos, G. P. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61684-0 · Cited by 644
Diagnosis and management of adrenal insufficiency
Bancos, I., Hahner, S., Tomlinson, J., & Arlt, W. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70142-1 · Cited by 467
Self-citationCorticotropin tests for hypothalamic-pituitary- adrenal insufficiency: a metaanalysis
Kazlauskaite, R., Evans, A. T., Villabona, C. V., Abdu, T. A. M., Ambrosi, B., Atkinson, A. B., Choi, C. H., Clayton, R. N., Courtney, C. H., Gonc, E. N., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0710 · Cited by 385
“Agha and colleagues (28) reported that only 3–8% of patients with an intermediate response to SDCT (30 min cortisol, 18.”
BackgroundSchneider, H. J., Aimaretti, G., Kreitschmann-Andermahr, I., Stalla, G.-K., & Ghigo, E. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60673-4 · Cited by 336
Systemic glucocorticoid therapy and adrenal insufficiency in adults: a systematic review
Joseph, R. M., Hunter, A. L., Ray, D. W., & Dixon, W. G. (2016) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2016.03.001 · Cited by 179
“Adrenal function can be tested using the short ACTH stimulation test (250 m g), as performed in 57% groups in this study; this produces equivalent results to the gold-standard insulin tolerance test (used in 14%), but is safer, and carries good long-term predictive value [95,96].”
The approach to the adult with newly diagnosed adrenal insufficiency
Arlt, W. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0032 · Cited by 165
Glucocorticoid induced adrenal insufficiency
Prete, A., & Bancos, I. (2021) · BMJ · doi:10.1136/bmj.n1380 · Cited by 155
Woods, C. P., Argese, N., Chapman, M., Boot, C., Webster, R., Dabhi, V., Grossman, A. B., Toogood, A. A., Arlt, W., Stewart, P. M., et al. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0608 · Cited by 152
Self-citationAdrenal insufficiency: etiology, diagnosis and treatment
Neary, N., & Nieman, L. (2010) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e328338f608 · Cited by 140
Adrenocortical dysfunction in liver disease: A systematic review
Fede, G., Spadaro, L., Tomaselli, T., Privitera, G., Germani, G., Tsochatzis, E., Thomas, M., Bouloux, P.-M., Burroughs, A. K., & Purrello, F. (2012) · Hepatology · doi:10.1002/hep.25573 · Cited by 135
Kokshoorn, N. E., Wassenaar, M. J. E., Biermasz, N. R., Roelfsema, F., Smit, J. W. A., Romijn, J. A., & Pereira, A. M. (2010) · European Journal of Endocrinology · doi:10.1530/eje-09-0601 · Cited by 129
Adrenal insufficiency: Physiology, clinical presentation and diagnostic challenges
Martin‐Grace, J., Dineen, R., Sherlock, M., & Thompson, C. J. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.01.029 · Cited by 128
Sbardella, E., Isidori, A. M., Woods, C. P., Argese, N., Tomlinson, J. W., Shine, B., Jafar‐Mohammadi, B., & Grossman, A. B. (2017) · Clinical Endocrinology · doi:10.1111/cen.13232 · Cited by 89
“In the present study we have confirmed that there is a strong correlation between 338 basal morning cortisol and the response to Synacthen administration, as previously 339 described (8, 23, 26).”
BackgroundMethodResultInfluentialSelf-citationLebbe, M., & Arlt, W. (2013) · Clinical Endocrinology · doi:10.1111/cen.12097 · Cited by 86
Radiation-induced hypopituitarism
Fernandez, A., Brada, M., Zabuliene, L., Karavitaki, N., & Wass, J. A. H. (2009) · Endocrine-Related Cancer · doi:10.1677/erc-08-0231 · Cited by 84
“41% present some degree of RIH (Agha et al. 2006) 38.”
BackgroundUpdate on adrenal insufficiency in patients with liver cirrhosis
Trifan, A. V., Chiriac, S., & Stanciu, C. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i4.445 · Cited by 85
Technical details influence the diagnostic accuracy of the 1 μg ACTH stimulation test
Wade, M., Baid, S., Calis, K., Raff, H., Sinaii, N., & Nieman, L. (2010) · European Journal of Endocrinology · doi:10.1530/eje-09-0746 · Cited by 83
Investigation of the Hypothalamo-pituitary-adrenal (HPA) axis: a contemporary synthesis
Karaca, Z., Grossman, A. B., & Keleştimur, F. (2021) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-020-09611-3 · Cited by 83
Melmed, S. K. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1409 · Cited by 73
“A prospective study rigorously defined the predictive accuracy of the Cortrosyn stimulation test (39).”
BackgroundPofi, R., Feliciano, C., Sbardella, E., Argese, N., Woods, C. P., Grossman, A. B., Jafar-Mohammadi, B., Gleeson, H., Lenzi, A., Isidori, A. M., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00529 · Cited by 67
Self-citationThe diagnosis and investigation of adrenal insufficiency in adults
Wallace, I., Cunningham, S., & Lindsay, J. (2009) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1258/acb.2009.009101 · Cited by 68
Giordano, R., Picu, A., Bonelli, L., Balbo, M., Berardelli, R., Marinazzo, E., Corneli, G., Ghigo, E., & Arvat, E. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03141.x · Cited by 67
Lodish, M., Dunn, S. V., Sinaii, N., Keil, M. F., & Stratakis, C. A. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2325 · Cited by 63
Reimondo, G., Bovio, S., Allasino, B., Terzolo, M., & Angeli, A. (2008) · Pituitary · doi:10.1007/s11102-008-0108-4 · Cited by 69
Kline, G., Buse, J., & Krause, R. (2017) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2017.02.008 · Cited by 62
Borresen, S. W., Klose, M., Baslund, B., Rasmussen, Å. K., Hilsted, L., Friis-Hansen, L., Locht, H., Hansen, A., Hetland, M. L., Lydolph, M. C., et al. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0251 · Cited by 63
Traumatic brain injuries induced pituitary dysfunction: a call for algorithms
Gilis-Januszewska, A., Kluczyński, Ł., & Hubalewska-Dydejczyk, A. (2020) · Endocrine Connections · doi:10.1530/ec-20-0117 · Cited by 50
“Cortisol values between 3 and 18 ug/dl require further investigation through stimulating tests, of which short synacthen test is commonly used [108].”
MethodThe Role of Estrogen in the Treatment of Men with Schizophrenia
Kulkarni, J., Gavrilidis, E., Worsley, R., Rheenen, T. E. V., & Hayes, E. (2013) · Intern J Endocrinol Metab · doi:10.5812/ijem.6615 · Cited by 68
Arlt, W. (2008) · Clinical Medicine · doi:10.7861/clinmedicine.8-2-211 · Cited by 52
Sacre, K., Dehoux, M., Chauveheid, M. P., Chauchard, M., Lidove, O., Roussel, R., & Papo, T. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1394 · Cited by 52
Post-Traumatic Hypopituitarism—Who Should Be Screened, When, and How?
Quinn, M., & Agha, A. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00008 · Cited by 54
“The choice of the dynamic test for adrenal reserves will depend on the preference of the endocrinologist but we prefer the corticotrophin test (Synacthen test) as a simple and reliable test (35).”
MethodSelf-citationYo, W. S., Toh, L., Brown, S. J., Howe, W. D., Henley, D. E., & Lim, E. M. (2014) · Clinical Endocrinology · doi:10.1111/cen.12373 · Cited by 47
Which patient requires neuroendocrine assessment following traumatic brain injury, when and how?
Glynn, N., & Agha, A. (2013) · Clinical Endocrinology · doi:10.1111/cen.12010 · Cited by 47
Self-citationThe frequency and the diagnosis of pituitary dysfunction after traumatic brain injury
Glynn, N., & Agha, A. (2019) · Pituitary · doi:10.1007/s11102-019-00938-y · Cited by 36
Self-citationFarholt, S., Sode-Carlsen, R., Christiansen, J. S., Østergaard, J. R., & Höybye, C. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0782 · Cited by 48
“Both tests are considered valuable in testing for primary as well as secondary AI (20, 27, 28).”
BackgroundPelewicz, K., & Miśkiewicz, P. (2021) · Diagnostics · doi:10.3390/diagnostics11040728 · Cited by 44
“Diagnostic tests for AI include a short stimulation test with synthetic ACTH (SST), insulin tolerance test (ITT), metyrapone stimulation test, CRH stimulation test, and glucagon stimulation test.”
BackgroundMethodInfluentialApproach to the Patient With Glucocorticoid-induced Adrenal Insufficiency
Borresen, S. W., Klose, M., Glintborg, D., Watt, T., Andersen, M., & Feldt‐Rasmussen, U. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac151 · Cited by 48
Finucane, F. M., Liew, A., Thornton, E., Rogers, B., Tormey, W., & Agha, A. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03240.x · Cited by 40
Self-citationCozzi, R. C., Lasio, G. B., Cardia, A., Felisati, G., Montini, M., & Attanasio, R. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03346486 · Cited by 42
Charoensri, S., Chailurkit, L., Muntham, D., & Bunnag, P. (2017) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2017.01.001 · Cited by 37
“In clinical practice, they are set at 18–20 lg/dL, with very low false negative results [4,5].”
BackgroundVincent, R. P., Etogo-Asse, F. E., Dew, T., Bernal, W., Alaghband-Zadeh, J., & le Roux, C. W. (2009) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1258/acb.2009.009030 · Cited by 37
Iatrogenic adrenal insufficiency in adults
Martin‐Grace, J., Tomkins, M., O’Reilly, M., & Sherlock, M. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00929-x · Cited by 40
“In practice, the short synacthen test is also commonly used to diagnose SAI and TAI and has been validated against both clinical outcomes and the insulin tolerance test 245–247 .”
National UK audit of the Short Synacthen® Test
Chatha, K. K., Middle, J. G., & Kilpatrick, E. S. (2010) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1258/acb.2009.009209 · Cited by 30
Burt, M. G., Mangelsdorf, B. L., Rogers, A., Ho, J. T., Lewis, J. G., Inder, W. J., & Doogue, M. P. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3576 · Cited by 30
“The peak cortisol after ACTH1–24 stimulation provides important prognostic information regarding HPA function in pituitary patients (6).”
BackgroundBorresen, S. W., Thorgrimsen, T. B., Jensen, B., Hilsted, L., Bartels, E. M., Feldt‐Rasmussen, U., & Locht, H. (2020) · Rheumatology · doi:10.1093/rheumatology/keaa011 · Cited by 31
Adrenal insufficiency in patients with decompensated cirrhosis
Karagiannis, A., Nakouti, T., Pipili, C., & Cholongitas, E. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i8.1112 · Cited by 32
The Rational Use of Pituitary Stimulation Tests
Petersenn, S., QUABBE, H.-J., Schöfl, C., Stalla, G. K., von Werder, K., & Buchfelder, M. (2010) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2010.0437 · Cited by 47
Karamouzis, I., Pagano, L., Prodam, F., Mele, C., Zavattaro, M., Busti, A., Marzullo, P., & Aimaretti, G. (2015) · Endocrine · doi:10.1007/s12020-015-0796-2 · Cited by 28
“2 years; only two patients developed a clear-cut adrenal insufficiency, another two presented a persisting diagnostic uncertainty, and seven had adrenal insufficiency after subsequent pituitary surgery or irradiation [39].”
BackgroundExtended endoscopic transplanum–transtuberculum approach for pituitary adenomas
Barazi, S. A., Pasquini, E., D’Urso, P. I., Zoli, M., Mazzatenta, D., Sciarretta, V., & Frank, G. (2012) · British Journal of Neurosurgery · doi:10.3109/02688697.2012.741739 · Cited by 25
Dekkers, O. M., Timmermans, J. M., Smit, J. W. A., Romijn, J. A., & Pereira, A. M. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0621 · Cited by 26
Karangizi, A. H. K., Al-Shaghana, M., Logan, S., Criseno, S., Webster, R., Boelaert, K., Hewins, P., & Harper, L. (2019) · BMC Nephrology · doi:10.1186/s12882-019-1354-6 · Cited by 23
Venkatesh, B., & Cohen, J. (2015) · Clinical Endocrinology · doi:10.1111/cen.12702 · Cited by 24
Wildi-Runge, S., Deladoëy, J., Bélanger, C., Deal, C., Vliet, G. V., Alos, N., & Huot, C. (2013) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2013.01.011 · Cited by 23
Cortisol: ACTH ratio to test for primary hypoadrenalism: a pilot study
Lee, M. K. V., Vasikaran, S., Doery, J. C. G., Wijeratne, N., & Prentice, D. (2013) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2012-131723 · Cited by 22
Garrahy, A., & Agha, A. (2016) · BMC Endocrine Disorders · doi:10.1186/s12902-016-0117-7 · Cited by 23
“In a study of 148 hypothalamic-pituitary patients who passed the SST and were not treated with hydrocortisone, only 2 patients subsequently developed adrenal insufficiency, one with suspected evolving hypopituitarism and one who had a borderline response [36].”
BackgroundMethodInfluentialSelf-citationDepth and duration of hypoglycaemia achieved during the insulin tolerance test
Ajala, O., Lockett, H., Twine, G., & Flanagan, D. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0068 · Cited by 23
Olsen, H., Kjellbom, A., Löndahl, M., & Lindgren, O. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01029 · Cited by 23
“Contrarily, in secondary adrenal insufficiency, normal adrenocortical cells lose their ability to respond to short ACTH stimulation after a period of continuously low ACTH (22).”
Valentin, A., Borresen, S. W., Rix, M., Elung‐Jensen, T., Sørensen, S. S., & Feldt‐Rasmussen, U. (2019) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfz180 · Cited by 22
Munro, V., Elnenaei, M., Doucette, S., Clarke, D. B., & Imran, S. A. (2018) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2018.02.010 · Cited by 20
Baek, J. H., Kim, S. K., Jung, J. H., Hahm, J. R., & Jung, J. (2016) · Endocrinology and Metabolism · doi:10.3803/enm.2016.31.1.153 · Cited by 19
Bancos, I., Erickson, D., Bryant, S., Hines, J., Nippoldt, T. B., Natt, N., & Singh, R. (2015) · Endocrine Practice · doi:10.4158/ep15820.or · Cited by 19
“Thus, accepting a cut-off of 20 mg/dL (550 nmol/L) at 30 rather than 60 minutes (35) will accordingly correspond to a higher free cortisol cut-off.”
BackgroundGlucocorticoids and Water Balance: Implications for Hyponatremia Management and Pituitary Surgery
Castle‐Kirszbaum, M., Goldschlager, T., Shi, M. D. Y., & Fuller, P. J. (2023) · Neuroendocrinology · doi:10.1159/000530701 · Cited by 17
Anterior pituitary hormone replacement therapy—a clinical review
Auernhammer, C. J., & Vlotides, G. (2007) · Pituitary · doi:10.1007/s11102-007-0001-6 · Cited by 17
“5th percentile of normal subjects [12] and”
BackgroundZüger, T., Jordi, M., Laimer, M. W., & Stettler, C. (2014) · Swiss Medical Weekly · doi:10.4414/smw.2014.13987 · Cited by 18
Brown, S. J., Hadlow, N. C., Badshah, I., & Henley, D. (2017) · Clinical Endocrinology · doi:10.1111/cen.13405 · Cited by 17
Que reste-t-il de l'insuffisance surrénale post-corticothérapie?
Goichot, B., Vinzio, S., Luca, F., & Schlienger, J.-L. (2007) · La Presse Médicale · doi:10.1016/j.lpm.2006.11.014 · Cited by 18
Ortiz-Flores, A. E., Santacruz, E., Mendiguchía, L. J., Cano, A. M. G., Nattero‐Chávez, L., Escobar-Morreale, H. F., & Luque‐Ramírez, M. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-019273 · Cited by 17
“We excluded the following from the analysis: (1) 7 subjects submitted to dynamic tests other than SST, such as ITT (n=2), corticotrophin-releasing hormone test (n=2), oral glucose tolerance test (n=2) and glucagon stimulation test (n=1); (2) 36 subjects aged below 18 years; (3) 20 subjects with a follow-up shorter tha…”
MethodPredicting recovery of the hypothalamic-pituitary-adrenal axis after prolonged glucocorticoid use
Leong, S. H., Shander, S., & Ratnasingam, J. (2018) · Endocrine Practice · doi:10.4158/ep-2017-0074 · Cited by 15
Samarasinghe, S., Emanuele, M. A., & Mazhari, A. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-7020-4087-0.00047-4 · Cited by 15
Ferrante, E., Morelli, V., Giavoli, C., Mantovani, G., Verrua, E., Sala, E., Malcmiodi, E., Bergamaschi, S., Profka, E., Cairoli, E., et al. (2012) · HORMONES · doi:10.14310/horm.2002.1374 · Cited by 17
Adrenal insufficiency secondary to glucocorticoid withdrawal in patients with brain tumor
Silva, A. N. D., & Schiff, D. (2007) · Surgical Neurology · doi:10.1016/j.surneu.2006.07.018 · Cited by 17
Diddhenipothage, S. A. D. M., Beck, K., Loo, H., Amiyangoda, C. G. K., Pofi, R., Tomlinson, J., & Pal, A. (2023) · Clinical Endocrinology · doi:10.1111/cen.14934 · Cited by 17
Self-citationThe low-dose corticotropin-stimulation test revisited: the less, the better?
Stewart, P. M., & CLARK, P. M. S. (2008) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet1038 · Cited by 15
“Values close to the cut-off levels of any test might be difficult to interpret, but far more data are available on the follow-up of patients with 'borderline' values obtained by the standard-dose SST than by low-dose SST”
BackgroundSelf-citationBioletto, F., Berton, A. M., Varaldo, E., Cuboni, D., Bona, C., Parasiliti‐Caprino, M., Prencipe, N., Ghigo, E., Grottoli, S., Maccario, M., et al. (2022) · Journal of Endocrinological Investigation · doi:10.1007/s40618-022-01926-z · Cited by 13
Kosák, M., Dušková, M., Stárka, L., Jandíková, H., Pospíšilová, H., SRAMKOVA, M., Hána, V., Kršek, M., Springer, D., & Šimůnková, K. (2017) · Physiological Research · doi:10.33549/physiolres.933729 · Cited by 13
“Partial AI, with maximal cortisol levels from 510 to 550 nmol/l, is a term used by some authors (Agha et al. 2006).”
MethodKosák, M., Hána, V., Hill, M., Šimůnková, K., Lacinová, Z., Kršek, M., & Marek, J. (2014) · Physiological Research · doi:10.33549/physiolres.932611 · Cited by 16
“(Hurel et al. 1996, Agha et al. 2006).”
BackgroundResultThe 1 μg cosyntropin test in normal individuals: A reappraisal
Anantharaman, R., Menezes, G., Yusuf, R., Ganapathi, B., Ayyar, S., & Srinivasan, R. (2013) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.113763 · Cited by 12
“[11] The cut offs for a clear pass response for the 1 and 250 g tests have been classically derived as a response above the 5th percentile response in a group of normal individuals for each test.[12-14]”
MethodGhajar, L. D., Heickman, L. K. W., Conaway, M. R., & Rogol, A. D. (2019) · Clinical Pediatrics · doi:10.1177/0009922818825154 · Cited by 12
A comparison of salivary steroid levels during diagnostic tests for adrenal insufficiency
Dušková, M., Šimůnková, K., Vítků, J., Sosvorová, L., Jandíková, H., Pospíšilová, H., Šrámková, M., Kosák, M., Kršek, M., Hána, V., et al. (2016) · Prague Medical Report · doi:10.14712/23362936.2016.2 · Cited by 11
“The possibility therefore exists when giving a 1 μg Synacthen dose that the patient does not actually receive any of the test drugs (Dickstein et al., 1991; Murphy et al., 1998; Agha et al., 2006; Wallace et al., 2009; Chatha et al., 2010).”
BackgroundJoseph, S. P., Ho, J. T., Doogue, M. P., & Burt, M. G. (2011) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2011.02582.x · Cited by 13
Outcomes of the short Synacthen test: what is the role of the 60 min sample in clinical practice?
Dineen, R., Mohamed, A. H. H., Gunness, A., Rakovac, A., Cullen, E., Barnwell, N., Neary, C., Behan, L., Boran, G. P., Gibney, J., et al. (2019) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2019-136669 · Cited by 10
Disorders of the adrenal cortex
Sherlock, M., & Gurnell, M. (2020) · doi:10.1093/med/9780198746690.003.0249 · Cited by 10
Adrenal Insufficiency in Cystic Fibrosis: A Rare Phenomenon?
Préville-Ratelle, S., Coriati, A., Ménard, A., Bourdeau, I., Tremblay, F., & Berthiaume, Y. (2018) · Canadian Respiratory Journal · doi:10.1155/2018/3629031 · Cited by 10
Cortisol levels in central adrenal insufficiency: light and shade.
Sanctis, V. D., Soliman, A. T., Yassin, M. A., & Garofalo, P. (2015) · PubMed · Cited by 9
National German Audit of Diagnosis, Treatment, and Teaching in Secondary Adrenal Insufficiency
Petersenn, S., Honegger, J. B., & Quinkler, M. O. (2017) · Hormone and Metabolic Research · doi:10.1055/s-0043-105077 · Cited by 10
“Indeed, this is the only test, for which longterm outcome correlation has been published, supporting its use in clinical practice [33].”
Evaluation of different hydrocortisone treatment strategies in transsphenoidal pituitary surgery
Fridman-Bengtsson, O., Höybye, C., Porthén, L., Stjärne, P., Hulting, A., & Sunnergren, O. (2019) · Acta Neurochirurgica · doi:10.1007/s00701-019-03885-6 · Cited by 9
“One of the reasons may be difficulties in diagnosing and defining a suboptimal function of the HPA axis [1, 3, 24].”
BackgroundHána, V., Ježková, J., Kosák, M., Kršek, M., Marek, J., Netuka, D., Hill, M., & Hána, V. (2015) · Physiological Research · doi:10.33549/physiolres.932875 · Cited by 10
“We used a 250 µg ACTH stimulation test, which is widely accepted and its utility was confirmed in many studies (Agha et al. 2006)(Abdu et al. 1999)(Tordjman et al. 2000).”
BackgroundMethodKamrath, C., & Boehles, H. (2010) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2010.174 · Cited by 8
Management of Glucocorticoid Replacement in Adult Growth Hormone Deficiency
Nyström, H. F., & Johannsson, G. (2007) · Hormone Research in Paediatrics · doi:10.1159/000097573 · Cited by 8
“Furthermore, in a recent study of 148 patients with pituitary disease who had cortisol responses in the 2.5 to 15th percentiles (510–635 nmol/l) of normal according to the 30-min high-dose SST, only 2 patients developed adrenal insufficiency during follow-up (mean, 4.2 years) that was not otherwise explained by subseq…”
MethodInfluentialAlgorithm for Screening of Adrenal Function in Stable Patients with Cirrhosis
Paz‐Delgadillo, J., Monreal‐Robles, R., Villarreal‐Pérez, J. Z., Lavalle-Gonzalez, F. J., Maldonado-Garza, H. J., & Bosques‐Padilla, F. (2017) · Annals of Hepatology · doi:10.5604/01.3001.0010.2797 · Cited by 7
Hypopituitarism and Growth Hormone Deficiency
Burt, M. G., & Ho, K. K. Y. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00011-1 · Cited by 10
Risk assessment, diagnosis, and treatment of cancer treatment-related adrenal insufficiency
Hayes, A. G., Rushworth, R. L., & Torpy, D. J. (2022) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2022.2023009 · Cited by 7
“These patients are likely to remain well and asymptomatic under normal conditions but are unable to mount an adequate response to metabolic stress [117,118].”
BackgroundDiagnosis and management of secondary adrenal crisis
Martel‐Duguech, L., Poirier, J., Bourdeau, I., & Lacroix, A. (2024) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-024-09877-x · Cited by 8
“The ACTH stimulation test (Synacthen, Cosyntropin, or corticotropin test) is simple and safe and has become the method of choice in most centers for PAI [1, 126, 127, 129].”
Pokrzywa, A., Ambroziak, U., Foroncewicz, B., Macech, M., Pączek, L., Florczak, M., Mucha, K., & Bednarczuk, T. (2019) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.15091 · Cited by 8
Response of Cortisol Metabolites in the Insulin Tolerance Test and Synacthen Tests
Šimůnková, K., Dušková, M., Kosák, M., Kršek, M., Hána, V., Hill, M., Jandíková, H., Pospíšilová, H., SRAMKOVA, M., Bifulco, E., et al. (2015) · Physiological Research · doi:10.33549/physiolres.933133 · Cited by 5
Uncertainties in endocrine substitution therapy for central hypocortisolism
Swords, F. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-59602-4.00026-5 · Cited by 5
Assessment of the HPA Axis: Another New Test?
Grossman, A. B. (2015) · Endocrine · doi:10.1007/s12020-015-0728-1 · Cited by 5
Carides, M., Mehta, R., Louw, J. C., & Mohamed, F. (2024) · Endocrinology Diabetes and Metabolism Case Reports · doi:10.1530/edm-23-0136 · Cited by 4
Sensitivity of anterior pituitary hormones to irradiation
Sherlock, M., & Toogood, A. A. (2006) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.1.5.633 · Cited by 4
Chou, S. H.-H. (2011) · Hospital Medicine Clinics · doi:10.1016/j.ehmc.2011.11.005 · Cited by 5
Metadata
- Authors
- Agha, A., Tomlinson, J. W., Clark, P. M., Holder, G., & Stewart, P. M.
- Affiliations
- Queen Elizabeth Hospital Birmingham (GB)
- University of Birmingham (GB)
- University Hospitals Birmingham NHS Foundation Trust (GB)
- Corresponding author
- Agha, Amar
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2006-01
- Volume
- 91
- Issue
- 1
- Pages
- 43-47
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2072627503
- Cited by
- 141
- References
- 25
- Citations by year
- 2026: 5 · 2025: 3 · 2024: 4 · 2023: 4 · 2022: 6 · 2021: 4 · 2020: 6 · 2019: 8 · 2018: 8 · 2017: 7 · 2016: 6 · 2015: 13 · 2014: 8 · 2013: 10 · 2012: 11
- FWCI
- 6.52
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Keywords
- ACTH stimulation test, secondary adrenal insufficiency, hypothalamic-pituitary-adrenal axis, cortisol response, false-negative results, long-term follow-up, pituitary surgery, pituitary radiotherapy, cortisol, diagnostic accuracy
- MeSH terms
- Adenoma, Adolescent, Adrenal Insufficiency, Adrenocorticotropic Hormone, Adult, Aged, Aged, 80 and over, Empty Sella Syndrome, False Negative Reactions, Female, Follow-Up Studies, Humans, Hydrocortisone, Hypophysectomy, Hypothalamo-Hypophyseal System, Infarction, Male, Middle Aged, Pituitary Diseases, Pituitary Function Tests, Pituitary Neoplasms, Pituitary-Adrenal Function Tests, Predictive Value of Tests, Pregnancy, Retrospective Studies, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.